CD274 and neoplasm: The unique genetic mechanisms underlying PD-L1 over-expression in CNSHL and PMBL are fascinating and indicate that, in order to subvert an ongoing anti-tumor immune response, these lymphomas activate PD-1 ligand expression [3].